Five out of six patients in FDA authorized Expanded Access Program are showing a qualitative reduction in microglia activation (a key biomarker being observed) Foralumab to advance into Phase 2 human ...
An eight minute scan could replace painful spinal taps in diagnosing multiple sclerosis, a study has found. The neurological condition, which affects more than 150,000 people in the UK, occurs when ...
The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback